ArticleFrontiers in oncology2022

SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study.

Dingyun You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.